| Literature DB >> 29964066 |
Puneeta Tandon1, Kathleen Patricia Ismond2, Kenneth Riess3, Andres Duarte-Rojo4, Bandar Al-Judaibi5, Michael Andrew Dunn6, Jennifer Holman7, Nancy Howes8, Mark Joseph Franklin Haykowsky9, Deborah Ann Josbeno10, Margaret McNeely11.
Abstract
Physical inactivity, sarcopenia, and frailty are highly prevalent, independent predictors of morbidity and mortality in patients with cirrhosis. Across a range of chronic diseases, exercise training is a key recommendation supported by guidelines and, for some conditions, even by governmental funding of exercise programmes. Consistent with the broader chronic disease literature, the evidence for a benefit of exercise in cirrhosis is promising. Several small trials have reported significant improvements in muscle health (mass, strength, functional capacity), quality of life, fatigue, and reductions in the hepatic venous pressure gradient, without adverse events. With strong emerging evidence surrounding the substantial risks of sarcopenia/frailty and our first-hand experiences with liver pre-transplant exercise programmes, we contend that routine patient care in cirrhosis should include an exercise prescription. Some clinicians may lack the resources and necessary background to translate the existing evidence into a practicable intervention. Our team, comprised of physiotherapists, exercise physiologists, hepatologists, transplant specialists, and knowledge translation experts from six North American centres, has distilled the essential background information, tools, and practices into a set of information ready for immediate implementation into clinics ranging from a family practice setting to specialty cirrhosis clinics. Augmenting the rationale and evidence are supplementary materials including video and downloadable materials for both patients and the physician. Supporting the exercising patient is a section regarding information about nutrition, providing practical tips suitable for all patients with cirrhosis.Entities:
Keywords: 6-min walk test; End-stage liver disease; Frailty; Nutrition; Physical activity; Pre-habilitation; Pre-transplant candidate; Sarcopenia
Mesh:
Year: 2018 PMID: 29964066 DOI: 10.1016/j.jhep.2018.06.017
Source DB: PubMed Journal: J Hepatol ISSN: 0168-8278 Impact factor: 25.083